Cargando…

The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs

Drug resistance is the main obstacle to achieving cures with both conventional and targeted anticancer drugs. The emergence of acquired drug resistance is initially mediated by non-genetic transcriptional changes, which occur at a much higher frequency than mutations and may involve population-scale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharko, Amanda C., Lim, Chang-Uk, McDermott, Martina S. J., Hennes, Chuck, Philavong, Kingsavanh P., Aiken, Tiffanie, Tatarskiy, Victor V., Roninson, Igor B., Broude, Eugenia V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828184/ https://www.ncbi.nlm.nih.gov/pubmed/33445730 http://dx.doi.org/10.3390/cells10010144

Ejemplares similares

CDK7 Inhibition Is Effective in all the Subtypes of Breast Cancer: Determinants of Response and Synergy with EGFR Inhibition
por: McDermott, Martina S. J., et al.
Publicado: (2020)

Role of transcription-regulating kinase CDK8 in colon cancer metastasis
por: Liang, Jiaxin, et al.
Publicado: (2019)

Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer
por: McDermott, Martina S.J., et al.
Publicado: (2017)

Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo
por: Ding, Xiaokai, et al.
Publicado: (2022)

Identifying Cancers Impacted by CDK8/19
por: Roninson, Igor B., et al.
Publicado: (2019)

Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based Assay
por: Li, Jing, et al.
Publicado: (2019)

Systemic Toxicity Reported for CDK8/19 Inhibitors CCT251921 and MSC2530818 Is Not Due to Target Inhibition
por: Chen, Mengqian, et al.
Publicado: (2019)

Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes
por: Kokinos, Elena K., et al.
Publicado: (2023)

CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins
por: Chen, Mengqian, et al.
Publicado: (2023)

Identification of novel genes that regulate androgen receptor signaling and growth of androgen-deprived prostate cancer cells
por: Levina, Elina, et al.
Publicado: (2015)

Structure of a zosuquidar and UIC2-bound human-mouse chimeric ABCB1
por: Alam, Amer, et al.
Publicado: (2018)

Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types
por: Erokhin, Maksim, et al.
Publicado: (2021)

The CDK-activating kinase Cdk7: Taking yes for an answer
por: Schachter, Miriam Merzel, et al.
Publicado: (2013)

Regulatory functions of the Mediator kinases CDK8 and CDK19
por: Fant, Charli B., et al.
Publicado: (2018)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
por: Dannappel, Marius Volker, et al.
Publicado: (2019)

The cryoelectron microscopy structure of the human CDK-activating kinase
por: Greber, Basil J., et al.
Publicado: (2020)

CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
por: Hara, Naofumi, et al.
Publicado: (2023)

RASSF1 is identified by transcriptome coordination analysis as a target of ATF4
por: Zhang, Youwen, et al.
Publicado: (2023)

JNKs function as CDK4-activating kinases by phosphorylating CDK4 and p21
por: Colleoni, B, et al.
Publicado: (2017)

Cdk5: An Emerging Kinase in Pain Signaling
por: Pareek, Tej Kumar, et al.
Publicado: (2012)

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma
por: Makhlin, Igor, et al.
Publicado: (2019)

CDK8 as the STAT1 serine 727 kinase?
por: Staab, Julia, et al.
Publicado: (2013)

The awakening of the CDK10/Cyclin M protein kinase
por: Guen, Vincent J., et al.
Publicado: (2017)

Phosphorylation of mixed lineage kinase MLK3 by cyclin-dependent kinases CDK1 and CDK2 controls ovarian cancer cell division
por: Cedeno-Rosario, Luis, et al.
Publicado: (2022)

Search for Potent and Selective Aurora A Inhibitors Based on General Ser/Thr Kinase Pharmacophore Model
por: Vasilevich, Natalya I., et al.
Publicado: (2016)

Compartmentalisation of EGFR signalling might potentiate the optimal use of EGFR tyrosine kinase inhibitors in cancer therapeutics
por: Karamouzis, M V, et al.
Publicado: (2007)

Mms19 is a mitotic gene that permits Cdk7 to be fully active as a Cdk-activating kinase
por: Nag, Rishita Narendra, et al.
Publicado: (2018)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells
por: Kang, Jian, et al.
Publicado: (2014)

A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
por: McLaughlin, Ronan P., et al.
Publicado: (2019)

The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis
por: Hakem, Anne, et al.
Publicado: (1999)

Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16
por: Dixon-Clarke, Sarah E., et al.
Publicado: (2017)

Cyclin-dependent kinases and CDK inhibitors in virus-associated cancers
por: Tavakolian, Shaian, et al.
Publicado: (2020)

Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review
por: Łukasik, Paweł, et al.
Publicado: (2021)

Single-cell heterogeneity of EGFR and CDK4 co-amplification is linked to immune infiltration in glioblastoma
por: Walentynowicz, Kacper A., et al.
Publicado: (2023)

EMP3 sustains oncogenic EGFR/CDK2 signaling by restricting receptor degradation in glioblastoma
por: Martija, Antoni Andreu, et al.
Publicado: (2023)

A kinase-independent role for CDK8 in BCR-ABL1(+) leukemia
por: Menzl, Ingeborg, et al.
Publicado: (2019)

The sequential phosphorylation of PHF10 subunit of the PBAF chromatin-remodeling complex determines different properties of the PHF10 isoforms
por: Sheynov, Andrey A., et al.
Publicado: (2020)

Pyruvate Kinase M2: A Potential Target for Regulating Inflammation
por: Alves-Filho, Jose C., et al.
Publicado: (2016)

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines
por: Coxon, Christopher R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f0g8j0pg0sv40mrg69qlpp6dqe